ThermoGenesis (NASDAQ: THMO)
ThermoGenesis Return vs. S&P
| 1 Year | 5 Year | 5 Year Annualized | Since IPO |
|---|
ThermoGenesis Company Info
ThermoGenesis Holdings, Inc. engages in the research, development, commercialization, and marketing of automated cell processing technologies for the cell and gene therapy field. It markets a full suite of solutions for automated clinical biobanking, point-of-care applications, and automation for immuno-oncology, including its semi-automated, CAR-Txpress platform, which streamlines the manufacturing process for the emerging CAR-T immunotherapy market. The company was founded by Philip H. Coelho in 1986 and is headquartered in Rancho Cordova, CA.
News & Analysis
Why ThermoGenesis Stock Is Soaring Wednesday
The company's switch to a contract development and manufacturing organization is taking shape.
Biotech Prospects for a Sizzling Summer
Consider these biotech stocks to make your portfolio sizzle this summer.
Heads Up, Biotech Investors: Chapter 2
Get to know the timing of major catalysts for stocks that may be on your biotech watch list.
ThermoGenesis Is Ready to Heat Up
As it nears profitability, ThermoGenesis is positioned for gains.
ThermoGenesis' Cold, Hard Cash
Sales may be light, but ThermoGenesis' wallet is heavy.
Foolish Forecast: ThermoGenesis Begins
But we're still waiting on some test results.
Valuation
Related Stocks
Premium Investing Services
Invest better with The Motley Fool. Get stock recommendations, portfolio guidance, and more from The Motley Fool's premium services.